Getting the Facts Right
Flibanserin—the long-awaited “pink pill” for women with Hypoactive Sexual Desire Disorder (HSDD)—was finally approved by the FDA last August, after years of debate. But so far the only women who’ve actually been able to try it have been subjects in clinical research trials. No woman has yet to be able to get a prescription for it from her doctor.
That’s going to change at the end of this week. Starting October 17, a woman will actually be able to take a prescription for flibanserin (which is marketed by Sprout Pharmaceuticals under the trade name Addyi) to her pharmacy.
What’s the best way for a woman to know whether flibanserin/Addyi would be safe and effective for her? Good question. There’s a lot of misleading information out there. (More on that in future blog posts).
Your best move is usually to ask your doctor. But there aren’t many doctors yet who know much about this new medication.
So I’ve prepared this list to get you started: 25 things a woman should know before considering taking Addyi.